You just read:

Keryx Biopharmaceuticals Announces Commencement of Phase 3 Program of Ferric Citrate (Zerenex™) in Japan by Partner, Japan Tobacco and Torii Pharmaceutical

News provided by

Keryx Biopharmaceuticals, Inc.

Apr 18, 2011, 08:30 ET